http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Brookmount Gold Provides Indonesian Production Update
-
AmeraMex International Secures $1.1 Million in Equipment Orders and Finalizes the Installation of a $4.4 Million Rental Agreement with a U.S. Army Base
-
RDAR Announces Filing of Corporate Name Change to Telvantis, Inc.
-
Trucept, Inc. Officially Changes Operating Name to Afinida, Inc. for Improved Business Continuity
-
Operation HOPE Founder John Hope Bryant and Business Leader Chaitra Dalton-Bryant Honored with Medal of Valor by Auschwitz Jewish Center Foundation
-
Ratio Therapeutics Partners with Macrocyclics for Exclusive Manufacturing and Distribution of its Radiopharmaceutical Chelator Platform
-
Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
-
Aurania Shareholders Approve All Resolutions at Annual Meeting
-
AST SpaceMobile (ASTS) Announces Settlement Term Sheet Facilitating Long-Term Access to up to 45 MHz of Premium Lower Mid-Band Spectrum in North America for Direct-to-Device Satellite Applications
-
Benton Substantially Increases Land Position at Newly Acquired Dominion Project 21 km North-Northeast of Calibre's Marathon Mine with Second Purchase Agreement
-
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
-
Turnium Technology Group Announces Upsized Convertible Debenture Offering
-
AST SpaceMobile Announces Settlement Term Sheet Facilitating Long-Term Access to up to 45 MHz of Premium Lower Mid-Band Spectrum in North America for Direct-to-Device Satellite Applications
-
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025
-
Merck (MRK) Announces FDA Approval of KEYTRUDA for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment
-
FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiother
-
Bitget's May Report Highlights 21% increase in Futures Trading Volume Accelerating it to top #3 exchange
-
Bitget's May Report Highlights 21% increase in Futures Trading Volume Accelerating it to top #3 exchange
-
Play For Dream MR Headset Powers Next-Gen LBE Experiences at AWE USA 2025
-
STARS LIGHT UP THE NIGHT SKY AS NORTH SHORE ANIMAL LEAGUE AMERICA'S "CELEBRATION OF RESCUE" GALA ROCKS DOWNTOWN NYC IN HONOR OF ANIMAL RESCUE AND ADOPTION
-
Bitget Onchain Rolls Out Major Feature Upgrades to Empower Smarter Trading
-
Nerdaxe Hydro Unveils Its First-Ever Liquid-Cooled NerdQaxe+ Miner
-
Bitget Sponsors The Inaugural Crypto Jazz Festival at Montreux
-
Hakone Retreat Offers a Unique Highland Experience to Cool All Five Senses
-
Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders
-
Coinchange and Kanga Exchange Partnership Drives 30% User Adoption For Passive Income
-
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
-
Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses
-
Walking the walk: Alectra raises over $10k to support YWCA Hamilton’s fight against gender-based violence
-
Descartes Systems Group (DSGX) announces AGM results
-
Monroe University Confers Degrees on 2,785 Students Representing 65 Countries at Annual Commencement
-
Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
-
Descartes Announces Results of Annual Meeting of Shareholders
-
FOBI AI Inc. Announces Closing of the Sale of German Subsidiary
-
Merck (MRK) Animal Health Receives EU CVMP Positive Opinion for NUMELVI Tablets for Dogs
-
Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs
-
Expro Group (XPRO) Announces New Chief Financial Officer
-
Expro Announces New Chief Financial Officer
-
DBV Technologies to Participate in Upcoming EAACI Congress 2025
-
American Water Recognized for Excellence in Water Quality by Partnership for Safe Water
-
Trepp Announces May 2025 Future CRE Leaders Award Winners in Commercial Real Estate
-
Lavras Gold Announces Results of 2025 Annual & Special Meeting
-
U.S. State Department: due to increased regional tensions, U.S. Advises its citizens in the Middle East and North Africa region to exercise increased caution
-
Cumulus Media’s Westwood One Presents Exclusive Multiplatform Audio Coverage of the 2025 NCAA® Men’s College World Series Championships
-
Christopher Simmons’ MuseWire again ranked among the Top 70 Music Industry Blogs for 2025 by Feedspot
-
XRP News: Strong Momentum Spotted in Nimanode Presale as It Explodes Past 15% of Softcap - Don’t Miss Out
-
DeFi Development (DFDV) to Host Twitter Spaces Explaining ELOCs, S-1s, and Capital Strategy
-
DeFi Development Corp. to Host Twitter Spaces Explaining ELOCs, S-1s, and Capital Strategy
-
Holy Family Hospital Healthcare Professionals Vote Overwhelmingly to Unionize with MNA to Ensure Excellent Patient Care and Secure Professional Respect
-
CUNARD'S NEWLY REFRESHED QUEEN ELIZABETH ARRIVES TO SEATTLE FOR THE FIRST TIME IN A SPECIAL SERIES OF VOYAGES TO ALASKA
